| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 08/17/2005 | EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS |
| 08/17/2005 | EP0990650B1 Tricyclic pyrrole or pyrazole derivatives |
| 08/17/2005 | CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/16/2005 | US6930105 Tetracyclicazaindoles and indolines having 5-HT activity |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/11/2005 | WO2005073239A1 Method for purifying quinolinecarboxylic acid derivative |
| 08/11/2005 | WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 08/11/2005 | US20050176786 Anticancer agents; inhibit Abelson tyrosine kinase, Ron receptor tyrosine kinase, Met receptor tyrosine kinase, Fms-like tyrosine kinase-3, or p21-activated kinase-4; e.g. 3-substituted-5-(carbonylamino or sulfonamido)-1H-pyrazolo[3,4-d]thiazole |
| 08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
| 08/11/2005 | US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse |
| 08/11/2005 | US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 08/11/2005 | DE102004003888A1 Mesoionische Pigmente Mesoionic pigments |
| 08/10/2005 | EP1560827A1 Anti-infective agents |
| 08/10/2005 | EP1560488A2 Antibacterial agents |
| 08/10/2005 | EP1395570B1 Oxazin(thi)one compounds used as fungicides |
| 08/10/2005 | EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 08/10/2005 | CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/09/2005 | US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 08/04/2005 | WO2005070928A1 2,4-dioxopyrimidine-based mesoionic pigments |
| 08/04/2005 | WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors |
| 08/04/2005 | WO2005070893A2 Azadecalin glucocorticoid receptor modulators |
| 08/04/2005 | WO2005049735A3 A process for aqueous milling of quinacridone pigments |
| 08/04/2005 | WO2005040355A3 Tao kinase modulators and methods of use |
| 08/04/2005 | US20050171345 Pteridine compounds for the treatment of psoriasis |
| 08/04/2005 | US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity |
| 08/04/2005 | US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity |
| 08/04/2005 | US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy |
| 08/04/2005 | US20050171122 Mitotic kinesin inhibitors |
| 08/04/2005 | US20050171108 Having 6-position substituent; sulfonylurea herbicides and intermediates; simple, low cost, high yield; transition metal catalytic reaction of leaving group with organometallic compound |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171087 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives |
| 08/04/2005 | US20050167637 cycloquaterbenzoxazoles, cycloquaternaphthoxazoles, cycloquaterbenzimidazoles and cycloquaternaphthimidazoles, used in photoactive performance chemicals, such as charge generating compounds in organic light emitter diodes,as phase transfer catalysts, dispersants in pigments or optical recording media |
| 08/04/2005 | CA2552419A1 Azadecalin glucocorticoid receptor modulators |
| 08/03/2005 | EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias |
| 08/03/2005 | EP1558600A1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 08/03/2005 | EP1357124B1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 08/03/2005 | CN1649879A Non-steroidal progesterone receptor modulators |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
| 07/28/2005 | WO2005068473A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators |
| 07/28/2005 | WO2005048948A3 Urea derivatives as kinase modulators |
| 07/28/2005 | WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 07/28/2005 | WO2004098498A3 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 07/28/2005 | US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165024 Urea derivatives as kinase modulators |
| 07/28/2005 | CA2547703A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 07/27/2005 | EP1556053A1 Antiinflammation agents |
| 07/27/2005 | EP1343766B1 Cyclization process step in the making of quinolones and naphthyridines |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/21/2005 | WO2005066184A1 Novel indeno[2,1a]indenes and isoindol[2,1-a]indoles |
| 07/21/2005 | WO2005066146A1 Method for the production of a thiazolo[3,4,5-de][4,1]benzothiazepine-type product |
| 07/21/2005 | WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | US20050159423 Antibacterial compounds |
| 07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 07/21/2005 | US20050159411 Bactericides for infrections in man |
| 07/20/2005 | EP1554272A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 07/20/2005 | EP1553967A1 Use of amide derivative of ge 2270 factor a3 for the treatment of acne |
| 07/20/2005 | CN1642961A Aminomethyl-substituted thiazolobenzimidazole derivative |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1211385C Bicyclic imidazo-5-yl-amine derivs. |
| 07/19/2005 | US6919450 Process for the preparation of benazepril |
| 07/19/2005 | US6919331 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 07/14/2005 | WO2005063764A2 Fused pyrrolocarbazoles and methods for the preparation thereof |
| 07/14/2005 | WO2005062882A2 Rifamycin analogs and uses thereof |
| 07/14/2005 | US20050153979 Novel piperidine-substituted indoles-or heteroderivatives thereof |
| 07/14/2005 | US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 07/14/2005 | CA2551611A1 Thiazole derivatives for treating or preventing parkinson's disease |
| 07/14/2005 | CA2550729A1 Rifamycin analogs and uses thereof |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1551850A1 2" oxo-voruscharin and derivatives thereof |
| 07/13/2005 | EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/13/2005 | CN1639148A 喹啉衍生物 Quinoline derivatives |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1637000A Imidazole ring-containing compound and organic electroluminescence display device |
| 07/13/2005 | CN1636999A Benzobisazole-base compound |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/12/2005 | US6916806 Such as 2-(2-isopropylphenyl)imino-5,5-dimethyl-1,3-thiazine which has binding activity to the cannabinoid type-2 receptors |
| 07/07/2005 | WO2005061519A1 Kinase inhibitors |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | US20050148642 Metabotropic glutamate receptor antagonists containing a saturated oxygen- or nitrogen-containing ring or a cycloalkyl ring, e.g., N-methyl-N-neopentyl-6-[(oxetan-3-ylamino)methyl]thiazolo[3,2-a]benzimidazole-2-carboxamide, having excellent oral activity, used especially for treating neuropathic pain |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | US20050148603 Compositions useful as inhibitors of protein kinases |
| 07/07/2005 | US20050148602 Inhibitors of alphaLbeta2 mediated cell adhesion |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/06/2005 | EP1549626A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
| 07/06/2005 | EP1549278A2 M sb 3 /sb MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1635891A Tetrahydroquinoline analogues as muscarinic agonists |
| 07/05/2005 | US6914068 Thiazolo[4,5-b]pyridines as fungicides |